Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of Cardiorespiratory Fitness Measurements in Adolescents.
Migliano P, Kabiri LS, Cross M, Butcher A, Frugé A, Brewer W, Ortiz A. Migliano P, et al. Among authors: cross m. J Funct Morphol Kinesiol. 2019 Jul 13;4(3):44. doi: 10.3390/jfmk4030044. J Funct Morphol Kinesiol. 2019. PMID: 33467359 Free PMC article.
alpha(1A) adrenergic receptor induces eukaryotic initiation factor 4E-binding protein 1 phosphorylation via a Ca(2+)-dependent pathway independent of phosphatidylinositol 3-kinase/Akt.
Rybkin II, Cross ME, McReynolds EM, Lin RZ, Ballou LM. Rybkin II, et al. Among authors: cross me. J Biol Chem. 2000 Feb 25;275(8):5460-5. doi: 10.1074/jbc.275.8.5460. J Biol Chem. 2000. PMID: 10681523 Free article.
Although the PE-induced phosphorylation of 4E-BP1 was blocked by the phosphatidylinositol 3-kinase inhibitor LY294002, neither phosphatidylinositol 3-kinase nor Akt, its downstream effector, is activated in cells treated with PE (Ballou, L. M., Cross, M. E., …
Although the PE-induced phosphorylation of 4E-BP1 was blocked by the phosphatidylinositol 3-kinase inhibitor LY294002, neither phosphatidyli …
Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
Devlin LA, Hu Z, Merhar SL, Ounpraseuth ST, Simon AE, Lee JY, Das A, Crawford MM, Greenberg RG, Smith PB, Higgins RD, Walsh MC, Rice W, Paul DA, Maxwell JR, Fung CM, Wright T, Ross J, McAllister JM, Crowley M, Shaikh SK, Christ L, Brown J, Riccio J, Wong Ramsey K, Braswell EF, Tucker L, McAlmon K, Dummula K, Weiner J, White JR, Newman S, Snowden JN, Young LW; Eunice Kennedy Shriver NICHD Neonatal Research Network and NIH Environmental Influences on Child Health Outcomes (ECHO) Program Institutional Development Award States Pediatric Clinical Trials Network. Devlin LA, et al. JAMA Pediatr. 2024 Apr 15:e240544. doi: 10.1001/jamapediatrics.2024.0544. Online ahead of print. JAMA Pediatr. 2024. PMID: 38619854 Free PMC article.
Injury in Starting and Replacement Players from Five Professional Men's Rugby Unions.
Roberts SP, Stokes KA, Williams S, West SW, Kemp S, Cross M, Moore IS, Bitchell CL, Mathema P, Quarrie K, McDonald W, Fortington L, Rubio Del Castillo E, Readhead C, Sewry N, Falvey É, Tucker R. Roberts SP, et al. Among authors: cross m. Sports Med. 2024 Apr 12. doi: 10.1007/s40279-024-02014-3. Online ahead of print. Sports Med. 2024. PMID: 38609697
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.
Pillai R, LeBoeuf SE, Hao Y, New C, Blum JLE, Rashidfarrokhi A, Huang SM, Bahamon C, Wu WL, Karadal-Ferrena B, Herrera A, Ivanova E, Cross M, Bossowski JP, Ding H, Hayashi M, Rajalingam S, Karakousi T, Sayin VI, Khanna KM, Wong KK, Wild R, Tsirigos A, Poirier JT, Rudin CM, Davidson SM, Koralov SB, Papagiannakopoulos T. Pillai R, et al. Among authors: cross m. Sci Adv. 2024 Mar 29;10(13):eadm9859. doi: 10.1126/sciadv.adm9859. Epub 2024 Mar 27. Sci Adv. 2024. PMID: 38536921 Free PMC article.
1,408 results